Lepu (Beijing) Medical Equipment Co., Ltd. was established in 1999, which was jointly funded by the 725th Research Institute of China Shipbuilding Industry Corporation and WP Company of the United States. The company is mainly engaged in the research, development, production and sales of coronary intervention medical devices, and it is one of the few enterprises in the field of high-end medical devices in China that can form strong competition with foreign products.
Since its establishment, the company has successively completed the research and development and industrialization of a number of interventional medical core products, such as stents and catheters, and was the first in the industry to obtain the product registration certificate of "coronary stent delivery system" (Class III) issued by the State Medical Supplies Administration.
The first anti-infection "drug central venous catheter" was successfully developed and trial-produced, and it was the first bioabsorbable stent in China to treat intravascular stenosis in patients with primary coronary atherosclerosis.